Gastroenterology Research and Practice / 2016 / Article / Tab 5

Research Article

Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience

Table 5

Initial intervention modalities per BCLC tumor stage.

Initial interventionBCLC
0ABCD

PEI520101
RFA226505
TACE0221900
TARE02710
Sorafenib001190
Best supportive care15313218
Resection03600
Transplant01101

BCLC: Barcelona Clinic Liver Cancer; TACE: transarterial chemoembolization; TARE: transarterial radioembolization; RFA: radiofrequency ablation; PEI: percutaneous ethanol injection.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.